A BILL 
To report data on COVID–19 immigration detention facilities 
and local correctional facilities that contract with U.S. 
Immigration and Customs Enforcement, and for other 
purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘COVID–19 in Immi-
4
gration Detention Data Transparency Act’’. 
5
20:13 May 06, 2021
H1681
2 
•HR 1681 IH
SEC. 2. DEFINITIONS. 
1
In this Act: 
2
(1) CBP DETENTION
FACILITY.—The term 
3
‘‘CBP detention facility’’ means any facility used by 
4
U.S. Customs and Border Protection to detain non-
5
citizens. 
6
(2) CDC DIRECTOR.—The term ‘‘CDC Direc-
7
tor’’ means the Director of the Centers for Disease 
8
Control and Prevention. 
9
(3) CONTRACT
DETENTION
FACILITY.—The 
10
term ‘‘contract detention facility’’ means any facility 
11
used for the detention of noncitizens that is operated 
12
by a government agency or a private entity that has 
13
contracted with U.S. Immigration and Customs En-
14
forcement, U.S. Customs and Border Protection, or 
15
the Office of Refugee Resettlement to provide such 
16
detention services, including service processing cen-
17
ters, juvenile detention facilities, family residential 
18
centers, facilities holding noncitizens awaiting re-
19
moval, holding facilities, and similar facilities oper-
20
ating under an intergovernmental service agreement 
21
with any of such Federal agencies, including inter-
22
governmental agreements with the United States 
23
Marshals Service. 
24
20:13 May 06, 2021
H1681
3 
•HR 1681 IH
(4) 
COVID–19.—The 
term 
‘‘COVID–19’’ 
1
means the 2019 novel coronavirus disease caused by 
2
the SARS–CoV–2 virus. 
3
(5) COVID–19 DIAGNOSTIC TEST.—The term 
4
‘‘COVID–19 diagnostic test’’ means a test— 
5
(A) that is an in vitro diagnostic product 
6
(as defined in section 809.3 of title 21, Code of 
7
Federal Regulations) for the detection of 
8
SARS–CoV–2; and 
9
(B) the administration of which— 
10
(i) is approved, cleared, or authorized 
11
under section 510(k), 513, 515, or 564 of 
12
the Federal Food, Drug, and Cosmetic Act 
13
(21 U.S.C. 360(k), 360c, 360e, 360bbb–3); 
14
(ii) the developer has requested, or in-
15
tends to request, emergency use authoriza-
16
tion under section 564 of the Federal 
17
Food, Drug, and Cosmetic Act (21 U.S.C. 
18
360bbb–3), unless and until the emergency 
19
use authorization request under such sec-
20
tion 564 has been denied or the developer 
21
of such test does not submit a request 
22
under such section within a reasonable 
23
timeframe; 
24
20:13 May 06, 2021
H1681
4 
•HR 1681 IH
(iii) is developed in and authorized by 
1
a State that has notified the Secretary of 
2
Health and Human Services of its inten-
3
tion to review tests intended to diagnose 
4
COVID–19; or 
5
(iv) is another test that the Secretary 
6
determines appropriate in guidance. 
7
(6) COVID–19 EMERGENCY DATA COLLECTION 
8
PERIOD.—The term ‘‘COVID–19 emergency data 
9
collection period’’ means the period beginning on the 
10
date of enactment of this Act and ending on the 
11
date that is 1 year after the date on which the pub-
12
lic health emergency declaration under section 319 
13
of the Public Health Service Act (42 U.S.C. 247d), 
14
with respect to COVID–19, terminates. 
15
(7) COVID–19 
RISK
FACTORS.—The term 
16
‘‘COVID–19 risk factors’’ includes advanced age, 
17
underlying conditions, and other factors identified by 
18
the Centers for Disease Control and Prevention. 
19
(8) FACILITY STAFF.—The term ‘‘facility staff’’ 
20
includes all individuals who work in a detention fa-
21
cility, including any individual who regularly reports 
22
for work within the detention facility, regardless of 
23
the actual employer of such individual. 
24
20:13 May 06, 2021
H1681
5 
•HR 1681 IH
(9) ICE 
DETENTION
FACILITY.—The term 
1
‘‘ICE detention facility’’ means any facility used by 
2
U.S. Immigration and Customs Enforcement to de-
3
tain or process noncitizens, including service proc-
4
essing centers and hold rooms. 
5
(10) ORR CONTRACTED
FACILITY
OR
PRO-
6
GRAM.—The term ‘‘ORR contracted facility or pro-
7
gram’’ means any facility or program in which unac-
8
companied noncitizen children are in the care and 
9
custody of the Department of Health and Human 
10
Services. 
11
(11) PUBLIC HEALTH EMERGENCY.—The term 
12
‘‘public health emergency’’ means— 
13
(A) a national emergency involving Federal 
14
primary responsibility determined to exist by 
15
the President under section 501(b) of the Rob-
16
ert T. Stafford Disaster Relief and Emergency 
17
Assistance Act (42 U.S.C. 5191(b)) with re-
18
spect to a communicable disease; 
19
(B) a national emergency declared by the 
20
President under sections 201 and 301 of the 
21
National Emergencies Act (50 U.S.C. 1621 and 
22
1631) with respect to a communicable disease; 
23
(C) a national public health emergency de-
24
clared by the Secretary of Health and Human 
25
20:13 May 06, 2021
H1681
6 
•HR 1681 IH
Services under section 319 of the Public Health 
1
Service Act (42 U.S.C. 247d); or 
2
(D) a global pandemic declared by the 
3
World Health Organization. 
4
SEC. 3. COVID–19 DATA COLLECTION REQUIREMENTS. 
5
(a) FEDERAL DETENTION FACILITIES.—The Direc-
6
tor of U.S. Immigration and Customs Enforcement, the 
7
Commissioner of U.S. Customs and Border Protection, the 
8
Director of the Office of Refugee Resettlement, and any 
9
senior official acting in, or performing the duties of, any 
10
such position shall, during the COVID–19 emergency data 
11
collection period— 
12
(1) post daily updates on the public website of 
13
the applicable agency containing the information de-
14
scribed in section 5 with respect to staff working at 
15
ICE detention facilities, CBP detention facilities, or 
16
ORR contracted facilities or programs, respectively, 
17
and noncitizens detained at such facilities or served 
18
by such programs; 
19
(2) archive, on a weekly basis, the data de-
20
scribed in paragraph (1) so that it remains publicly 
21
accessible and in a machine readable format; and 
22
(3) beginning not later than the earlier of the 
23
date that is 14 days after the date on which the 
24
CDC Director publishes the guidance required under 
25
20:13 May 06, 2021
H1681
7 
•HR 1681 IH
section 4(a) or 45 days after the date of the enact-
1
ment of this Act, submit weekly reports to the CDC 
2
Director containing the information described in sec-
3
tion 5. 
4
(b) CONTRACT DETENTION FACILITIES.— 
5
(1) IN GENERAL.—Beginning not later than the 
6
earlier of the date that is 14 days after the date on 
7
which the CDC Director publishes the guidance re-
8
quired under section 4(a) or 45 days after the date 
9
of the enactment of this Act, the head of each con-
10
tract detention facility shall— 
11
(A) submit weekly reports to the Federal 
12
agency with which the facility is under contract 
13
and the public health authority of the State in 
14
which the facility is located containing the data 
15
described in section 5 with respect to staff 
16
working at such facility and noncitizens de-
17
tained at such facility; 
18
(B) post weekly updates containing the 
19
data described in subparagraph (A) on the pub-
20
lic website of the facility, if the facility has a 
21
public website, in a machine readable format, 
22
and archive prior updates so that they remain 
23
publicly accessible; and 
24
20:13 May 06, 2021
H1681
8 
•HR 1681 IH
(C) submit weekly reports containing the 
1
data referred to in subparagraph (A) to— 
2
(i) the Immigration Detention Om-
3
budsman designated pursuant to section 
4
405 of the Homeland Security Act of 2002 
5
(6 U.S.C. 205); and 
6
(ii) the Office for Civil Rights and 
7
Civil Liberties of the Department of 
8
Homeland Security. 
9
(2) SUBMISSION
OF
INFORMATION
TO
THE 
10
CDC.—Not later than 24 hours after a Federal agen-
11
cy receives the data described in paragraph (1), the 
12
head of such agency shall— 
13
(A) submit such data to the CDC Director; 
14
and 
15
(B) post such data to the public website of 
16
the agency, disaggregated by individual contract 
17
detention facility, which shall be archived week-
18
ly and shall remain publicly accessible in a ma-
19
chine readable format. 
20
(c) USE OF EXISTING APPROPRIATIONS.— 
21
(1) DEPARTMENT
OF
HEALTH
AND
HUMAN 
22
SERVICES.—The Department of Health and Human 
23
Services shall use amounts otherwise appropriated 
24
20:13 May 06, 2021
H1681
9 
•HR 1681 IH
for the Office of Refugee Resettlement to carry out 
1
its responsibilities under this section. 
2
(2) U.S. IMMIGRATION AND CUSTOMS ENFORCE-
3
MENT.—U.S. Immigration and Customs Enforce-
4
ment shall use amounts otherwise appropriated to 
5
the Custody Operations Account to carry out its re-
6
sponsibilities under this section. 
7
(3) U.S. 
CUSTOMS
AND
BORDER
PROTEC-
8
TION.—U.S. Customs and Border Protection shall 
9
use amounts otherwise appropriated to the Procure-
10
ment, Construction, and Improvements Account to 
11
carry out its responsibilities under this section. 
12
SEC. 4. CDC REPORTS. 
13
(a) GUIDANCE.—Not later than 30 days after the 
14
date of enactment of this Act, the CDC Director shall 
15
issue guidance for immigration detention facilities regard-
16
ing— 
17
(1) the categories of data required to be re-
18
ported under this Act; and 
19
(2) how the CDC Director will determine 
20
whether a Federal or State agency is in compliance 
21
with the requirements under this Act. 
22
(b) PUBLICATION ON WEBSITE.— 
23
(1) IN GENERAL.—Not later than 7 days after 
24
data is reported to the Centers for Disease Control 
25
20:13 May 06, 2021
H1681
10 
•HR 1681 IH
and Prevention pursuant to section 3, the CDC Di-
1
rector shall make such data available to the public 
2
on the website of the Centers for Disease Control 
3
and Prevention, including all data reported by U.S. 
4
Immigration and Customs Enforcement, U.S. Cus-
5
toms and Border Protection, and the Office of Ref-
6
ugee Resettlement. 
7
(2) WEEKLY ARCHIVAL.—The data referred to 
8
in paragraph (1) shall be archived weekly and shall 
9
remain publicly accessible in a machine readable for-
10
mat. 
11
(c) REPORTS TO CONGRESS.—Not later than 60 days 
12
after the date of the enactment of this Act, and monthly 
13
thereafter during the COVID–19 emergency data collec-
14
tion period, the CDC Director shall submit a report to 
15
the Committee on Homeland Security and Governmental 
16
Affairs of the Senate, the Committee on Health, Edu-
17
cation, Labor, and Pensions of the Senate, the Committee 
18
on the Judiciary of the Senate, the Committee on Home-
19
land Security of the House of Representatives, the Com-
20
mittee on Energy and Commerce of the House of Rep-
21
resentatives, and the Committee on the Judiciary of the 
22
House of Representatives that— 
23
(1) summarizes the information submitted by 
24
U.S. Immigration and Customs Enforcement, U.S. 
25
20:13 May 06, 2021
H1681
11 
•HR 1681 IH
Customs and Border Protection, the Office of Ref-
1
ugee Resettlement, and State public health authori-
2
ties pursuant to section 3; and 
3
(2) analyzes the trends and patterns of the dis-
4
ease outbreak and the care provided in immigration 
5
detention facilities and contracted facilities. 
6
SEC. 5. COVID–19 DATA. 
7
(a) IN GENERAL.—The data described in this section 
8
is the following data with respect to each ICE, CBP, ORR, 
9
and contract detention facility: 
10
(1) TESTING
NUMBERS.—Data related to 
11
COVID–19 diagnostic testing by such facilities, in-
12
cluding cumulative and new (since the previous 
13
weekly report) counts of— 
14
(A) the number of detained noncitizens 
15
tested for COVID–19, including the dates on 
16
which 
such 
tests 
were 
administered, 
17
disaggregated by— 
18
(i) first-time COVID–19 diagnostic 
19
tests and retests; and 
20
(ii) symptomatic and asymptomatic; 
21
(B) the number of detained noncitizens 
22
who have requested COVID–19 testing, includ-
23
ing the number of such requests that were de-
24
nied and the reasons for such denials; 
25
20:13 May 06, 2021
H1681
12 
•HR 1681 IH
(C) the number of facility staff tested for 
1
COVID–19, 
disaggregated 
by 
first-time 
2
COVID–19 diagnostic tests and retests; and 
3
(D) the COVID–19 diagnostic test devel-
4
oper and test name for each COVID–19 diag-
5
nostic test conducted. 
6
(2) TEST RESULTS.—Data related to COVID– 
7
19 diagnostic testing outcomes, including cumulative 
8
and new (since the previous weekly report) counts 
9
of— 
10
(A) the number of confirmed active cases 
11
of COVID–19 among detained noncitizens, 
12
disaggregated by— 
13
(i) first-time COVID–19 diagnostic 
14
tests and retests; and 
15
(ii) the COVID–19 diagnostic test de-
16
veloper and test name for each COVID–19 
17
diagnostic test used to confirm each active 
18
case; 
19
(B) the number of confirmed negative 
20
cases of COVID–19 among detained nonciti-
21
zens, disaggregated by— 
22
(i) first-time COVID–19 diagnostic 
23
tests and retests; and 
24
20:13 May 06, 2021
H1681
13 
•HR 1681 IH
(ii) the COVID–19 diagnostic test de-
1
veloper and test name for each COVID–19 
2
diagnostic test used to confirm each nega-
3
tive case; 
4
(C) the number of confirmed active cases 
5
of COVID–19 among detention facility staff, 
6
disaggregated by— 
7
(i) first-time COVID–19 diagnostic 
8
tests and retests; and 
9
(ii) the COVID–19 diagnostic test de-
10
veloper and test name for each COVID–19 
11
diagnostic test used to confirm each active 
12
case; 
13
(D) the number of confirmed negative 
14
cases of COVID–19 among detention facility 
15
staff, disaggregated by— 
16
(i) first-time COVID–19 diagnostic 
17
tests and retests; and 
18
(ii) the COVID–19 diagnostic test de-
19
veloper and test name for each COVID–19 
20
diagnostic test used to confirm each nega-
21
tive case; 
22
(E) the number of COVID–19 diagnostic 
23
tests pending results, disaggregated by detained 
24
noncitizens and detention facility staff; 
25
20:13 May 06, 2021
H1681
14 
•HR 1681 IH
(F) the average time between testing a de-
1
tained person for COVID–19 and receiving the 
2
results of the COVID–19 diagnostic test; and 
3
(G) the average time between testing a de-
4
tention facility employee for COVID–19 and re-
5
ceiving the results of the COVID–19 diagnostic 
6
test. 
7
(3) CASE
OUTCOMES.—COVID–19 case out-
8
comes, including cumulative and new (since the pre-
9
vious report) counts of— 
10
(A) the number of detained noncitizens 
11
hospitalized for a case of COVID–19, including 
12
the locations of the hospitals at which the non-
13
citizens are receiving treatment; 
14
(B) the number of detained noncitizens 
15
who have recovered from COVID–19; 
16
(C) the number of detained noncitizens 
17
currently in quarantine and the number of de-
18
tained noncitizens in medical isolation for infec-
19
tion with or exposure to COVID–19; 
20
(D) the number of detained noncitizens 
21
who have completed quarantine and the number 
22
of detained noncitizens who have been released 
23
from medical isolation; 
24
20:13 May 06, 2021
H1681
15 
•HR 1681 IH
(E) the number of detained noncitizens 
1
identified as having 1 or more COVID–19 risk 
2
factors; 
3
(F) the number of noncitizens who have 
4
been released from detention because of 1 or 
5
more COVID–19 risk factors, disaggregated by 
6
their applicable risk factor; 
7
(G) the number of detained noncitizens 
8
with active COVID–19 cases in the previous 
9
weekly report who are not included in the 
10
present report, disaggregated by the specific 
11
reason for such exclusion, including release, 
12
negative COVID–19 test, transfer, removal 
13
from the United States, and absence of 
14
COVID–19 symptoms; 
15
(H) the number of detained noncitizens 
16
who have died from COVID–19; 
17
(I) the number of detained noncitizens who 
18
died after testing positive for COVID–19, but 
19
the official cause of death was not COVID–19; 
20
(J) the number of detention facility staff 
21
hospitalized for a case of COVID–19; 
22
(K) the number of detention facility staff 
23
who have recovered from COVID–19; and 
24
20:13 May 06, 2021
H1681
16 
•HR 1681 IH
(L) the number of detention facility staff 
1
who have died from a case of COVID–19. 
2
(4) GENERAL MEDICAL ATTENTION.—The num-
3
ber of detained noncitizens who have requested gen-
4
eral medical attention, including the number of such 
5
requests that were denied and the reasons for such 
6
denials. 
7
(5) DAILY POPULATION.—Average daily popu-
8
lation of detained noncitizens for the week preceding 
9
the COVID–19 emergency data collection period and 
10
for all weeks during such period. 
11
(6) VACCINATIONS.—Data related to distribu-
12
tion of the COVID–19 vaccine, including— 
13
(A) the policies of the facility relating to 
14
the distribution of the COVID–19 vaccination 
15
to detained noncitizen persons and detention fa-
16
cility staff, including— 
17
(i) how the facility is prioritizing dis-
18
tribution among detention facility staff and 
19
detained noncitizens; and 
20
(ii) any changes or updates made to 
21
the policies; 
22
(B) the total number of COVID–19 vac-
23
cine doses that the facility has received up to 
24
the date of the report, disaggregated by the 
25
20:13 May 06, 2021
H1681
17 
•HR 1681 IH
types of COVID–19 vaccine the facility has re-
1
ceived; 
2
(C) the number of COVID–19 vaccine 
3
doses that the facility has in inventory as of the 
4
date of the report, disaggregated by the types 
5
of COVID–19 vaccine the facility has in inven-
6
tory; 
7
(D) the total number and percentage of de-
8
tained noncitizens— 
9
(i) who have been offered a COVID– 
10
19 vaccine, disaggregated by the types of 
11
COVID–19 vaccine offered at each facility; 
12
(ii) who received a first dose of the 
13
COVID–19 vaccine during the week imme-
14
diately preceding the date of the report, 
15
disaggregated by the types of COVID–19 
16
vaccine administered at each facility; 
17
(iii) who received a first dose of the 
18
COVID–19 vaccine before the date of the 
19
report, disaggregated by the type of 
20
COVID–19 vaccine administered at each 
21
facility; 
22
(iv) who are fully vaccinated, either 
23
because the person received a second dose 
24
of the COVID–19 vaccine or because the 
25
20:13 May 06, 2021
H1681
18 
•HR 1681 IH
COVID–19 vaccine the person received re-
1
quired only 1 dose, disaggregated by the 
2
type of COVID–19 vaccine administered at 
3
each facility; and 
4
(v) who refused the COVID–19 vac-
5
cine; 
6
(E) the total number and percentage of de-
7
tention facility staff— 
8
(i) who have been offered a COVID– 
9
19 vaccine, disaggregated by the type of 
10
COVID–19 vaccine offered at each facility; 
11
(ii) who received a first dose of the 
12
COVID–19 vaccine during the week imme-
13
diately preceding the date of the report, 
14
disaggregated by the type of COVID–19 
15
vaccine administered at each facility; 
16
(iii) who received a first dose of the 
17
COVID–19 vaccine before the date of the 
18
report, disaggregated by the types of 
19
COVID–19 vaccine administered at each 
20
facility; 
21
(iv) who are fully vaccinated, either 
22
because the person received a second dose 
23
of the COVID–19 vaccine or because the 
24
COVID–19 vaccine the person received re-
25
20:13 May 06, 2021
H1681
19 
•HR 1681 IH
quired only 1 dose, disaggregated by the 
1
type of COVID–19 vaccine administered at 
2
each facility; or 
3
(v) who refused the COVID–19 vac-
4
cine; and 
5
(F) in the case of detained noncitizens and 
6
detention facility staff described in subpara-
7
graph (D)(v) or (E)(v), respectively, the 3 most 
8
common reasons given for refusing the COVID– 
9
19 vaccine. 
10
(7) TRANSFERRED
NONCITIZENS.—Data re-
11
lated to the COVID–19 testing, results, and case 
12
outcomes (at the time of release) of noncitizens who 
13
were transferred between detention facilities during 
14
the reporting period, including— 
15
(A) the number of all individuals who were 
16
transferred, including— 
17
(i) the dates on which such transfers 
18
occurred; 
19
(ii) the number of such noncitizens 
20
who were tested and received a result be-
21
fore their transfer; and 
22
(iii) the number of such noncitizens 
23
who were not tested or did not receive a 
24
result before their transfer; 
25
20:13 May 06, 2021
H1681
20 
•HR 1681 IH
(B) the purposes of such transfers; 
1
(C) the dates on which COVID–19 testing 
2
occurred during the transfer process; 
3
(D) the number of transferees who tested 
4
positive at any point during the transfer proc-
5
ess; 
6
(E) the number of positive COVID–19 
7
cases in the transferring facility and in the ar-
8
riving facility at the time of each such transfer; 
9
(F) the number of transferees who received 
10
a first dose of the COVID–19 vaccine before 
11
being transferred, disaggregated by the type of 
12
COVID–19 vaccine administered; and 
13
(G) the number of transferees who were 
14
fully vaccinated before being transferred, either 
15
because the person received a second dose of 
16
the COVID–19 vaccine or because the COVID– 
17
19 vaccine the person received required only 1 
18
dose, disaggregated by the type of COVID–19 
19
vaccine administered. 
20
(8) RELEASED NONCITIZENS.—Data related to 
21
the COVID–19 testing, results, and case outcomes 
22
(at the time of release) of noncitizens who were re-
23
leased from detention, and juvenile noncitizens who 
24
were released from the custody of the Department of 
25
20:13 May 06, 2021
H1681
21 
•HR 1681 IH
Health and Human Services, during the reporting 
1
period, disaggregated by the type of release, and in-
2
cluding— 
3
(A) individuals released to alternatives to 
4
detention programs as a result of the COVID– 
5
19 public health emergency; 
6
(B) any recent positive COVID–19 tests 
7
and referrals to external medical care; 
8
(C) the number of noncitizens released who 
9
received a first dose of the COVID–19 vaccine 
10
before being released, disaggregated by the type 
11
of COVID–19 vaccine administered; and 
12
(D) the number of noncitizens who were 
13
fully vaccinated before being released, either be-
14
cause the person received a second dose of the 
15
COVID–19 vaccine or because the COVID–19 
16
vaccine the person received required only 1 
17
dose, disaggregated by the type of COVID–19 
18
vaccine administered. 
19
(9) REMOVED NONCITIZENS.—Data related to 
20
the COVID–19 testing, results, and case outcomes 
21
(at the time of removal or expulsion) of noncitizens 
22
who were deported from an ICE, CBP, ORR, or 
23
contract detention facility during the reporting pe-
24
riod, including— 
25
20:13 May 06, 2021
H1681
22 
•HR 1681 IH
(A) any recent positive COVID–19 tests 
1
and referrals to external medical care; 
2
(B) the number of noncitizens removed or 
3
expelled from the United States; 
4
(C) the number of such noncitizens who 
5
were tested and received a result before their 
6
removal or expulsion; 
7
(D) the number of such noncitizens who 
8
were not tested or did not receive a result be-
9
fore their removal or expulsion; 
10
(E) the number of such noncitizens who 
11
received a first dose of the COVID–19 vaccine 
12
before their removal, disaggregated by the type 
13
of COVID–19 vaccine administered; 
14
(F) the number of such noncitizens who 
15
were fully vaccinated before their removal, ei-
16
ther because the person received a second dose 
17
of the COVID–19 vaccine or because the 
18
COVID–19 vaccine the person received required 
19
only 1 dose, disaggregated by the type of 
20
COVID–19 vaccine administered; and 
21
(G) the countries to which noncitizens are 
22
removed or expelled from the United States. 
23
20:13 May 06, 2021
H1681
23 
•HR 1681 IH
(10) BOOK-INS.—Data related to facility book- 
1
ins, including cumulative and new (since the pre-
2
vious report) counts of— 
3
(A) the number of noncitizens booked into 
4
each facility, disaggregated by— 
5
(i) initial and total book-ins (including 
6
transfers); 
7
(ii) arresting agency; 
8
(iii) initial book-ins from ORR cus-
9
tody (if applicable); and 
10
(iv) initial book-ins from other Fed-
11
eral, State, or local government agencies, 
12
including the United States Marshals Serv-
13
ice and the Bureau of Prisons. 
14
(11) FACILITY STAFF.—The total number of fa-
15
cility staff during the current reporting period. 
16
(b) DISAGGREGATION OF DATA.— 
17
(1) IN GENERAL.—The data described in sub-
18
section (a) shall be disaggregated by sex, sexual ori-
19
entation, gender identity, age, race, ethnicity, dis-
20
ability, language spoken, last known place of resi-
21
dence, location at which the individual is being de-
22
tained, nationality, and statutory authority for de-
23
tention. 
24
20:13 May 06, 2021
H1681
24 
•HR 1681 IH
(2) EXCLUSION
OF
INDIVIDUALS
INCARCER-
1
ATED FOR NONIMMIGRATION REASONS AT CONTRACT 
2
DETENTION
FACILITIES.—Data regarding individ-
3
uals incarcerated at contract detention facilities for 
4
nonimmigration reasons shall be excluded from the 
5
data described in subsection (a). 
6
(c) DETENTION PERIOD.—The data described in sub-
7
section (a) with respect to detained noncitizens who are 
8
infected with COVID–19 shall include, to the extent prac-
9
ticable, the period of their detention. 
10
SEC. 6. PRIVACY PROTECTIONS. 
11
(a) IN GENERAL.—Any data collected, stored, re-
12
ceived, or published under this Act— 
13
(1) shall be collected, stored, received, or pub-
14
lished in a manner that protects the privacy of indi-
15
viduals whose information is included in such data; 
16
(2) shall be de-identified or anonymized in a 
17
manner that protects the identity of all individuals 
18
whose information is included in such data; 
19
(3) shall comply with privacy protections pro-
20
vided under the regulations promulgated under sec-
21
tion 264(c) of the Health Insurance Portability and 
22
Accountability Act of 1996 (42 U.S.C. 1320d–2 
23
note); and 
24
20:13 May 06, 2021
H1681
25 
•HR 1681 IH
(4) shall be limited in use for the purpose of 
1
public health and be protected from all other inter-
2
nal use by any entity that collects, stores, or receives 
3
the data, including use of such data in determina-
4
tions of eligibility (or continued eligibility) in health 
5
plans, and from any other inappropriate uses. 
6
(b) RESTRICTION ON USE OF COVID–19 STATUS IN 
7
IMMIGRATION PROCEEDINGS.—The Government may not 
8
use an noncitizen’s positive COVID–19 test, an nonciti-
9
zen’s treatment for COVID–19 symptoms, or the state of 
10
the COVID–19 pandemic in the noncitizen’s country of 
11
origin as evidence against the noncitizen in any immigra-
12
tion proceeding, including— 
13
(1) a proceeding to determine if the noncitizen 
14
is a public charge; and 
15
(2) proceedings involving asylum, withholding of 
16
removal, and protection under the Convention 
17
against Torture and Other Cruel, Inhuman or De-
18
grading Treatment or Punishment, done at New 
19
York December 10, 1984. 
20
SEC. 7. COVID–19 SAFETY PROTOCOLS AND PRACTICES. 
21
(a) IN GENERAL.—Not later than 30 days after the 
22
date of the enactment of this Act, the Director of U.S. 
23
Immigration and Customs Enforcement, the Commis-
24
sioner of U.S. Customs and Border Protection, the Direc-
25
20:13 May 06, 2021
H1681
26 
•HR 1681 IH
tor of the Office of Refugee Resettlement, and any senior 
1
official acting in, or performing the duties of, any such 
2
position shall submit a report to the congressional commit-
3
tees referred to in section 4(c) that identifies, for each 
4
detention facility under the jurisdiction of the applicable 
5
agency head, including contract detention facilities, the 
6
protocols and practices for protecting detained noncitizens 
7
from exposure to the novel coronavirus (SARS–CoV–2), 
8
including— 
9
(1) the health standards at the facility, includ-
10
ing— 
11
(A) the standards for transfer to hospital 
12
or other specialized care; 
13
(B) the procedure for the detained person 
14
to request and obtain a COVID–19 test and as-
15
sociated results; and 
16
(C) detained noncitizens access to informa-
17
tion about the facility’s COVID–19 plans and 
18
protocols; 
19
(2) the medical care provided to detained non-
20
citizens, including— 
21
(A) the specific efforts to cohort smaller 
22
groups of detained people; 
23
(B) the specific efforts to provide humane 
24
medical isolation to symptomatic people, and 
25
20:13 May 06, 2021
H1681
27 
•HR 1681 IH
separately, people who have tested positive for 
1
COVID–19; and 
2
(C) the standards for clinical monitoring of 
3
symptomatic and COVID–19 positive detained 
4
persons; and 
5
(3) the sanitation practices at the facility, in-
6
cluding the frequency and amount of detained non-
7
citizens’ access to soap and masks. 
8
(b) NOTIFICATION OF OUTBREAK OR EXPOSURE.— 
9
Each detention facility shall create, share, and enforce a 
10
process for notifying anyone who has recently entered or 
11
visited such facility of any COVID–19 outbreak or expo-
12
sure at such facility. 
13
SEC. 8. ACCESS TO LEGAL COUNSEL. 
14
Not later than 30 days after the date of the enact-
15
ment of this Act, and monthly thereafter, the Director of 
16
U.S. Immigration and Customs Enforcement, the Com-
17
missioner of U.S. Customs and Border Protection, the Di-
18
rector of the Office of Refugee Resettlement, the head of 
19
each contract detention facility, and any senior official act-
20
ing in, or performing the duties of, any such position shall 
21
submit a report to the congressional committees referred 
22
to in section 4(c) that identifies, for each detention facility 
23
for which he or she is responsible— 
24
20:13 May 06, 2021
H1681
28 
•HR 1681 IH
(1) the efforts made to ensure that each noncit-
1
izen detained in such facility has access to legal 
2
counsel; 
3
(2) if any detained noncitizen does not have ac-
4
cess to legal counsel, the changes being made to en-
5
sure universal access to legal counsel; 
6
(3) the number of telephones available to de-
7
tained noncitizens; 
8
(4) the number of detained noncitizens who 
9
have used the free telephone call minutes available 
10
to them; 
11
(5) the number of detained noncitizens who 
12
have access to video conference technology with their 
13
legal counsel and the number of detained noncitizens 
14
who have used video conference technology to com-
15
municate with their legal counsel; 
16
(6) the number of computers or internet-en-
17
abled portable electronic devices available to de-
18
tained noncitizens; and 
19
(7) the process for notifying the public when 
20
the facility is locked down because of an outbreak, 
21
including the accommodations made during such 
22
lockdowns to provide detained noncitizens with in-
23
creased access to telephones or videoconferencing. 
24
20:13 May 06, 2021
H1681
29 
•HR 1681 IH
SEC. 9. RIGHT OF DETAINED NONCITIZENS TO ACCESS 
1
TEST RESULTS. 
2
The Director of U.S. Immigration and Customs En-
3
forcement, the Commissioner of U.S. Customs and Border 
4
Protection, the Director of the Office of Refugee Resettle-
5
ment, the head of each contract detention facility, and any 
6
senior official acting in, or performing the duties of, any 
7
such position shall ensure that each detained noncitizen 
8
receives the results of, and any medical records related 
9
to, any COVID–19 diagnostic test administered to the 
10
noncitizen, in the noncitizen’s preferred language, and in 
11
a private and confidential manner, not later than 24 hours 
12
after such results become available. 
13
Æ 
20:13 May 06, 2021
H1681
